What’s neuro-scientists think about the Brain Chip from Elon Musk
The ambitious goals for Elon Musk for Neuralink were discussed in a live demonstration last week, but neuroscientists are still suspicious of the company's plans for the development of a brain machine interface.
Neuralink;s brain chip is a device that communicates directly with the brain of a person, reads brain signals, and even alters them to correct problems. Musk said he wanted the technology to help cure diseases in his brain and protect and improve the human brain.
But Dr. John Krakauer, Professor of Neuroscience at the Johns Hopkins Medical School and headmaster of the Brain, Learning, Movement and Movimiento Lab, said we're not close achieving the Musk Black Mirror-like objectives of regulating the hormone levels and directly transmitting music to people's minds.
He commented about this;
“These things are premature in a way because we are so far from that, and yet we are already excited and worried about these things,”
Krakauer is generally positive about the aims of Neuralink but admits that it needs to address some ethical concerns when inserting brain chips inside people. He said that researchers would understand the long-term effects and hazards of brain chips, such as inflammation or infection.
On the other hand, the ethical implications of a brain chip are also significant, as Musk said the device was very costly at first. The computer is also ethical.
Krakauer, however, said that he is generally excited and knows that some of the scientists have worked on Neuralink. Neuralink said that it will help with technological advancement and progress, but its presentation to date has provided a somewhat different tone.
For Krakauer and many others, it is important to concentrate on non-invasive therapies including immersive therapeutic experience based on animation for neural restore and neural rehabilitation. Krakauer said doctors don't have to go into the brain directly to see substantial effects.
“A lot of patients are suffering right now, and there are really interesting things that would help them, I’d rather we directly address patient needs right now rather than focus on something that’s more consumer-facing.”